Jijiwa et al. reported that CD44v6 is expressed on GBM stem-like cells and enhances in vitro and in vivo tumor growth, with a link to the upregulated expression of OPN (a ligand of CD44v6) [54]. The gene discussed is SPP1; the disease is glioblastoma.